Cvs Health Anti-diarrheal Vanilla Suspension
NDC Package 59779-883-12
Package Information
Cvs Health Anti-diarrheal Vanilla (bismuth subsalicylate) suspension is •shake well immediately before each use•adults and children 12 years of age and older: 30 ml or 2 tablespoonful•for accurate dosing, use convenient pre-measured dose cup•repeat dose every 1/2 hour to 1 hour as needed•do not exceed 8 doses in 24 hours•use until diarrhea stops but not more than 2 days•children under 12 years: ask a doctor•drink plenty of clear fluids to help prevent dehydration caused by diarrhea. This formulation utilizes a suspension delivery system. Marketed by Cvs Pharmacy,inc., this product is identified by NDC 59779-883 and is authorized under FDA application M008.
Identification & Billing
- RxCUI: 308762 - bismuth subsalicylate 525 MG in 30 mL Oral Suspension
- RxCUI: 308762 - bismuth subsalicylate 17.5 MG/ML Oral Suspension
- RxCUI: 308762 - bismuth subsalicylate 1.75 % Oral Suspension
- RxCUI: 308762 - bismuth subsalicylate 262 MG per 15 ML Oral Suspension
- RxCUI: 308762 - bismuth subsalicylate 524 MG per 30 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59779 - Cvs Pharmacy,inc.
- 59779-883 - Cvs Health Anti-diarrheal Vanilla
- 59779-883-12 - 355 mL in 1 BOTTLE, PLASTIC
- 59779-883 - Cvs Health Anti-diarrheal Vanilla
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59779-883-12 identifies a specific commercial package of 355 ml in 1 bottle, plastic of Cvs Health Anti-diarrheal Vanilla, a human over the counter drug labeled by Cvs Pharmacy,inc.. This suspension is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy,inc. on August 11, 2015. The current certification is valid through December 31, 2027.
How is this Cvs Pharmacy,inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59779088312. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.